Insights into pathogenic events of HIV-associated Kaposi sarcoma and immune reconstitution syndrome related Kaposi sarcoma
2008
Understanding HIV-Associated Kaposi Sarcoma and Immune Reconstitution Syndrome
publication
Evidence: moderate
Author Information
Author(s): Feller Liviu, Lemmer Johan
Primary Institution: University of Limpopo Medunsa Campus
Hypothesis
How does highly active antiretroviral treatment (HAART) affect the incidence and progression of HIV-associated Kaposi sarcoma (HIV-KS)?
Conclusion
HAART significantly reduces the incidence of HIV-KS and can lead to regression of some lesions, but a subset of patients may develop immune reconstitution inflammatory syndrome (IRIS) associated with HIV-KS.
Supporting Evidence
- HAART leads to a decrease in HIV and HHV-8 loads.
- Some patients may experience IRIS shortly after starting HAART.
- HIV-KS is characterized by complex interactions between HIV, HHV-8, and inflammatory cytokines.
Takeaway
This study shows that while treatment for HIV can help reduce a type of cancer called Kaposi sarcoma, some people might still get worse after starting treatment.
Limitations
The study does not specify the exact mechanisms of how HAART leads to IRIS in some patients.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website